The SURMOUNT-1 trial for tirzepatide showed average weight loss of 15% of starting body weight at 36 weeks (roughly 8.5 months)
Patients who should have potassium monitoring include: Those taking diuretics particularly thiazide or loop diuretics, which promote renal potassium loss and are commonly prescribed for hypertension or heart failure (BNF) Individuals with chronic kidney disease (CKD) impaired renal function affects potassium homeostasis, and these patients may have baseline electrolyte abnormalities Patients on renin-angiotensin-aldosterone system (RAAS) inhibitors ACE inhibitors, angiotensin receptor blockers (ARBs), and mineralocorticoid receptor antagonists can affect potassium balance, though typically causing hyperkalaemia (high potassium) rather than hypokalaemia [5] [6] Those with cardiac conditions including heart failure, arrhythmias, or ischaemic heart disease, where potassium imbalance poses particular risk Patients experiencing severe or persistent gastrointestinal side effects ongoing vomiting or diarrhoea significantly increases the risk of electrolyte depletion Clinical guidelines recommend checking urea and electrolytes (U&Es) at baseline for patients in at-risk groups before starting weight management interventions
The frequency of Polybion A Injection administration depends on the specific condition being treated and should be determined by a healthcare provider
If you feel weird, restless or confused when combining Suboxone with an antidepressant, talk to your provider about trying a different option or changing dosing
Depending on their subcellular localization and the existence of unique cis -acting regulatory elements in the upstream promoter region, various GPX genes respond differently to environmental stresses
